Can bevacizumab prolong survival for glioblastoma patients through multiple lines of therapy?

A.A. Brandes, W.P. Mason, J. Pichler, Anna Nowak, M. Gil, F.H. Saran, C. Révil, B. Lutiger, A.F. Carpentier

Research output: Contribution to journalArticlepeer-review

15 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Can bevacizumab prolong survival for glioblastoma patients through multiple lines of therapy?'. Together they form a unique fingerprint.

Medicine & Life Sciences